The DOI matches its Crossref record; 163 of the 165 references it cites were found in a registry or an index.
Linking chronic kidney disease and Parkinson’s disease: a literature review
Abstract
Chronic kidney disease (CKD) has been typically implicated in cardiovascular risk, considering the function the kidney has related to blood pressure, vitamin D, red blood cell metabolism, and electrolyte and acid-base regulation. However, neurological consequences are also attributed to this disease. Among these, recent large epidemiological studies have demonstrated an increased risk for Parkinson's disease (PD) in patients with CKD. Multiple studies have evaluated individually the association of blood pressure, vitamin D, and red blood cell dysmetabolism with PD, however, no study has reviewed the potential mechanisms related to these components in context of CKD and PD. In this review, we explored the association of CKD and PD and linked the components of the former to propose potential pathways explaining a future increased risk for PD, where renin-angiotensin system, oxidative stress, and inflammation have a main role. Potential preventive and therapeutic interventions based on these associations are also explored. More preclinical studies are needed to confirm the potential link of CKD conditions and future PD risk, whereas more interventional studies targeting this association are warranted to confirm their potential benefit in PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to the activation of the renin-angiotensin system in aged kidneys, there is an increase in angiotensin II levels which acts on angiotensin II type 1 receptors in the substantia nigra and striatum. This induces oxidative stress and inflammation, thereby increasing the risk of PD.258,259”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [259]
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Epidemiology of Parkinson’s disease
Tysnes, O.-B., & Storstein, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,414
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Distribution of the vitamin D receptor and 1α-hydroxylase in human brain
Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.08.006 · Cited by 1,444
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Babitt, J. L., & Lin, H. Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111078 · Cited by 1,041
The diagnosis of Parkinson’s disease
Tolosa, E., Wenning, G., & Poewe, W. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70285-4 · Cited by 902
Research works printed but not linked: 1
- Yue X, Li H, Yan H, Zhang P, Chang L, Li T (2016) Risk of Parkinson disease in diabetes mellitus. Medicine 95(18):e3549
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“This induces oxidative stress and in fl ammation, thereby increasing the risk of PD. 258,259 Lung – brain axis .”
Si, X., Dai, S., Fang, Y., Tang, J., Wang, Z., Li, Y., Song, Z., Chen, Y., Liu, Y., Zhao, G., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.03.004 · Cited by 145
Liabeuf, S., Pépin, M., Franssen, C. F. M., Viggiano, D., Carriazo, S. M., Gansevoort, R. T., Gesualdo, L., Hafez, G., Małyszko, J., Mayer, C. C., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab223 · Cited by 132
“CKD and Parkinson’s disease share some pathophysiologic mechanisms, such as oxidative stress, hypertension, vitamin D deficiency and anaemia (for a review, see [35]).”
BackgroundSousa, R. A. L. D., Caria, A. C. I., Aras, R., de Oliveira, E. M., Soci, Ú. P. R., & Cassilhas, R. C. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05082-9 · Cited by 131
Pandey, P., & Khan, F. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.05.011 · Cited by 122
Metadata
- Authors
- Meléndez-Flores, J. D., & Estrada-Bellmann, I.
- Affiliations
- Universidad Autónoma de Nuevo León (MX)
- Corresponding author
- Estrada-Bellmann, Ingrid
- Venue
- Metabolic Brain Disease
- Published
- 2020-09-29
- Volume
- 36
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0885-7490 (ISSN-L)
- 1573-7365
- OpenAlex
- W3091204915
- Cited by
- 44
- References
- 165
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 9 · 2023: 9 · 2022: 6 · 2021: 3
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Metabolic Brain Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- chronic kidney disease, Parkinson's disease, neurodegeneration risk, blood pressure, vitamin D, renin-angiotensin system, oxidative stress, inflammation, pathophysiological mechanisms, preventive interventions
- MeSH terms
- Humans, Inflammation, Parkinson Disease, Renin-Angiotensin System, Oxidative Stress, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Linking chronic kidney disease and Parkinson’s disease: a literature review. https://app.cochat.ai/papers/10.1007/s11011-020-00623-1
- The paper
- Meléndez-Flores, J. D., & Estrada-Bellmann, I. (2021). Linking chronic kidney disease and Parkinson’s disease: a literature review. Metabolic Brain Disease. https://doi.org/10.1007/s11011-020-00623-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.